Literature DB >> 19553319

Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates latency-associated nuclear protein-mediated suppression of lytic origin-dependent DNA synthesis.

Cyprian Rossetto1, Irena Yamboliev, Gregory S Pari.   

Abstract

The original cotransfection replication assay identified eight human herpesvirus 8 (HHV8)-encoded proteins required for origin-dependent lytic DNA replication. Previously, we demonstrated that under conditions where K-Rta is overexpressed, a K-bZIP knockout bacmid displayed an aberrant subcellular localization pattern for the latency-associated nuclear protein (LANA). Additionally, these same studies demonstrated that K-bZIP interacts with LANA in the absence of K-Rta and that K-bZIP does not directly participate in, but may facilitate, the initiation of lytic DNA synthesis. We developed a modification of the transient cotransfection replication assay wherein both lytic (oriLyt) and latent (terminal repeat) DNA replication are evaluated simultaneously. We now show that LANA represses origin-dependent lytic DNA replication in a dose dependent manner when added to the cotransfection replication assay. This repression was overcome by increasing amounts of a K-bZIP expression plasmid in the cotransfection mixture or by dominant-negative inhibition of the interaction of LANA with K-bZIP by the overexpression of the K-bZIP-LANA binding domain. Chromatin immunoprecipitation assays show that LANA interacts with oriLyt in the absence of K-bZIP expression, suggesting that suppression of lytic replication by LANA is mediated by direct binding. The interaction of K-bZIP with oriLyt was dependent upon the expression of LANA; however, LANA interacted with oriLyt independently of K-bZIP expression. These data suggest that the interaction of LANA with K-bZIP modulates lytic and latent replication and that K-bZIP facilitates lytic DNA replication and modulates the switch from the latent phase of the virus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553319      PMCID: PMC2738207          DOI: 10.1128/JVI.00922-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Carboxy terminus of human herpesvirus 8 latency-associated nuclear antigen mediates dimerization, transcriptional repression, and targeting to nuclear bodies.

Authors:  D R Schwam; R L Luciano; S S Mahajan; L Wong; A C Wilson
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Kaposi's sarcoma-associated herpesvirus LANA hitches a ride on the chromosome.

Authors:  Andrew J Barbera; Jayanth V Chodaparambil; Brenna Kelley-Clarke; Karolin Luger; Kenneth M Kaye
Journal:  Cell Cycle       Date:  2006-05-15       Impact factor: 4.534

3.  Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA.

Authors:  M E Ballestas; K M Kaye
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.

Authors:  T S Hyun; C Subramanian; M A Cotter; R A Thomas; E S Robertson
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Authors:  R Renne; C Barry; D Dittmer; N Compitello; P O Brown; D Ganem
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Authors:  C Lim; Y Gwack; S Hwang; S Kim; J Choe
Journal:  J Biol Chem       Date:  2001-06-25       Impact factor: 5.157

Review 7.  Structure and function of latency-associated nuclear antigen.

Authors:  S C Verma; K Lan; E Robertson
Journal:  Curr Top Microbiol Immunol       Date:  2007       Impact factor: 4.291

8.  Identification of a short amino acid sequence essential for efficient nuclear targeting of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 K8 protein.

Authors:  Stéphanie Portes-Sentis; Evelyne Manet; Géraldine Gourru; Alain Sergeant; Henri Gruffat
Journal:  J Gen Virol       Date:  2001-03       Impact factor: 3.891

9.  Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program.

Authors:  Qiuhua Li; Fuchun Zhou; Fengchun Ye; Shou-Jiang Gao
Journal:  Virology       Date:  2008-08-05       Impact factor: 3.616

10.  Kaposi's sarcoma-associated herpesvirus K-bZIP protein is necessary for lytic viral gene expression, DNA replication, and virion production in primary effusion lymphoma cell lines.

Authors:  Sylvain Lefort; Louis Flamand
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

View more
  21 in total

1.  A protein array screen for Kaposi's sarcoma-associated herpesvirus LANA interactors links LANA to TIP60, PP2A activity, and telomere shortening.

Authors:  Meir Shamay; Jianyong Liu; Renfeng Li; Gangling Liao; Li Shen; Melanie Greenway; Shaohui Hu; Jian Zhu; Zhi Xie; Richard F Ambinder; Jiang Qian; Heng Zhu; S Diane Hayward
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  Interaction of Kaposi's sarcoma-associated herpesvirus ORF59 with oriLyt is dependent on binding with K-Rta.

Authors:  Cyprian C Rossetto; Ni Ketut Susilarini; Gregory S Pari
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

3.  Kaposi's Sarcoma-Associated Herpesvirus K8 Is an RNA Binding Protein That Regulates Viral DNA Replication in Coordination with a Noncoding RNA.

Authors:  Dongcheng Liu; Yan Wang; Yan Yuan
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

4.  Molecular Biology of KSHV in Relation to HIV/AIDS-Associated Oncogenesis.

Authors:  Meilan He; Fan Cheng; Suzane Ramos da Silva; Brandon Tan; Océane Sorel; Marion Gruffaz; Tingting Li; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2019

5.  Characterization of de novo lytic infection of dermal lymphatic microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus.

Authors:  Gavin Golas; Juan D Alonso; Zsolt Toth
Journal:  Virology       Date:  2019-07-31       Impact factor: 3.616

6.  Initiation of lytic DNA replication in Epstein-Barr virus: search for a common family mechanism.

Authors:  Andrew J Rennekamp; Paul M Lieberman
Journal:  Future Virol       Date:  2010-01       Impact factor: 1.831

7.  Functional characterization of Kaposi's sarcoma-associated herpesvirus open reading frame K8 by bacterial artificial chromosome-based mutagenesis.

Authors:  Yan Wang; Narayanan Sathish; Charles Hollow; Yan Yuan
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats.

Authors:  Pravinkumar Purushothaman; Maria E McDowell; James McGuinness; Ruth Salas; Sharif M Rumjahn; Subhash C Verma
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

9.  Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.

Authors:  Jie Lu; Hem C Jha; Subhash C Verma; Zhiguo Sun; Shuvomoy Banerjee; Richard Dzeng; Erle S Robertson
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

10.  Chromatin immunoprecipitation and microarray analysis suggest functional cooperation between Kaposi's Sarcoma-associated herpesvirus ORF57 and K-bZIP.

Authors:  Olga V Hunter; Emi Sei; R Blake Richardson; Nicholas K Conrad
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.